STB
AVXL icon

S&T Bank’s Anavex Life Sciences AVXL Stock Holding History

S&T Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259 Hold
100
– – ﹤0.01% 440
2026
Q1 		$307 Hold
100
– – ﹤0.01% 406
2025
Q4 		$356 Hold
100
– – ﹤0.01% 401
2025
Q3 		$890 Hold
100
– – ﹤0.01% 445
2025
Q2 		$922 Hold
100
– – ﹤0.01% 429
2025
Q1 		$858 Hold
100
– – ﹤0.01% 381
2024
Q4 		$1.07K Buy
+100
New +$769 ﹤0.01% 251

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

S&T Bank's AVXL Position: Q2 2026 in Review

S&T Bank held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 100 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #440.

S&T Bank first reported a position in AVXL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.07K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • S&T Bank held 100 shares of Anavex Life Sciences worth $259 as of Q2 2026.
  • S&T Bank left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #440 holding.
  • S&T Bank first reported a position in Anavex Life Sciences in Q4 2024 and has held it in 7 quarters since.
  • S&T Bank's Anavex Life Sciences position peaked at $1.07K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.